Design and Synthesis of Novel β-Carboline Linked Amide Derivatives as Anticancer Agents

2019 ◽  
Vol 89 (3) ◽  
pp. 511-516 ◽  
Author(s):  
B. Ravinaik ◽  
D. Ramachandran ◽  
M. V. Basaveswara Rao
2020 ◽  
Vol 5 (39) ◽  
pp. 12317-12319
Author(s):  
Narasimha Swamy Thirukovela ◽  
Satheesh Kumar Nukala ◽  
Narsimha Sirassu ◽  
Ravinder Manchal ◽  
Prasad Gundepaka ◽  
...  

2019 ◽  
Vol 19 (7) ◽  
pp. 842-874 ◽  
Author(s):  
Harbinder Singh ◽  
Nihar Kinarivala ◽  
Sahil Sharma

We live in a world with complex diseases such as cancer which cannot be cured with one-compound one-target based therapeutic paradigm. This could be due to the involvement of multiple pathogenic mechanisms. One-compound-various-targets stratagem has become a prevailing research topic in anti-cancer drug discovery. The simultaneous interruption of two or more targets has improved the therapeutic efficacy as compared to the specific targeted based therapy. In this review, six types of dual targeting agents along with some interesting strategies used for their design and synthesis are discussed. Their pharmacology with various types of the molecular interactions within their specific targets has also been described. This assemblage will reveal the recent trends and insights in front of the scientific community working in dual inhibitors and help them in designing the next generation of multi-targeted anti-cancer agents.


2020 ◽  
Vol 5 (26) ◽  
pp. 7919-7922
Author(s):  
Satheesh Kumar Dende ◽  
Raghu Babu Korupolu ◽  
Krishnakanth Reddy Leleti

2017 ◽  
Vol 2017 ◽  
pp. 1-10 ◽  
Author(s):  
Vincenza Barresi ◽  
Carmela Bonaccorso ◽  
Domenico A. Cristaldi ◽  
Maria N. Modica ◽  
Nicolò Musso ◽  
...  

Recent drug discovery efforts are highly focused towards identification, design, and synthesis of small molecules as anticancer agents. With this aim, we recently designed and synthesized novel compounds with high efficacy and specificity for the treatment of breast tumors. Based on the obtained results, we constructed a Volsurf+ (VS+) model using a dataset of 59 compounds able to predict the in vitro antitumor activity against MCF-7 cancer cell line for new derivatives. In the present paper, in order to further verify the robustness of this model, we report the results of the projection of more than 150 known molecules and 9 newly synthesized compounds. We predict their activity versus MCF-7 cell line and experimentally verify the in silico results for some promising chosen molecules in two human breast cell lines, MCF-7 and MDA-MB-231.


2017 ◽  
Vol 44 (2) ◽  
pp. 749-767 ◽  
Author(s):  
Poojali P. Warekar ◽  
Kirti T. Patil ◽  
Priyanka T. Patil ◽  
Aniket P. Sarkate ◽  
Kshipra S. Karnik ◽  
...  

2016 ◽  
Vol 8 (3) ◽  
pp. 249-256 ◽  
Author(s):  
Nehal H Elghazawy ◽  
Mathias Engel ◽  
Rolf W Hartmann ◽  
Mostafa M Hamed ◽  
Nermin S Ahmed ◽  
...  

2021 ◽  
pp. 131937
Author(s):  
Purna Koteswara Rao Cherukumalli ◽  
Bhaskara Rao Tadiboina ◽  
Kali Charan Gulipalli ◽  
Srinu Bodige ◽  
Vishnu Nayak Badavath ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document